The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II
Autor: | Hasinoff, Brian B., Wu, Xing, Nitiss, John L., Kanagasabai, Ragu, Yalowich, Jack C. |
---|---|
Zdroj: | In Biochemical Pharmacology 15 December 2012 84(12):1617-1626 |
Databáze: | ScienceDirect |
Externí odkaz: |